Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
254.1 BRL | +0.42% |
|
+8.91% | +11.13% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an expected P/E ratio at 32.82 and 29.08 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.99 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company is not the most generous with respect to shareholders' compensation.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.13% | 67.59B | - | ||
-4.16% | 184B | C+ | ||
-2.39% | 103B | C | ||
+16.04% | 46.93B | B- | ||
-11.10% | 43.87B | B- | ||
+8.28% | 41.2B | B+ | ||
+17.63% | 30.47B | B | ||
+13.59% | 24.16B | A- | ||
-8.10% | 23.57B | A- | ||
-11.08% | 22.26B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BDX Stock
- B1DX34 Stock
- Ratings Becton, Dickinson and Company